Biocryst Pharmaceuticals Inc share price logo

Biocryst Pharmaceuticals Inc Share Price

NASDAQ: BCRX

Small Cap

$7.96

+0.26

(+3.44%)

as on

Biocryst Pharmaceuticals Inc Stock Performance

as on September 19, 2025 at 1:29 am IST

  • Day's Low

    $7.77
    $7.96
    downward going graph

    2.39%

    Downside

  • 52 Week's Low

    52 Week's High

    $6.02
    $11.31
    downward going graph

    24.43%

    Downside

    42.09%

    Upside

    downward going graph

Biocryst Pharmaceuticals Inc share price movements today

Previous Close
$7.70
Open
$7.78
Volume
1.5M
Day's Low - High
$7.77 - $7.96
52 Week Low - High
$6.02 - $11.31

Biocryst Pharmaceuticals Inc Historical Returns

1 Month Return
-8.11 %
3 Month Return
-22.69 %
1 Year Return
-3.27 %
3 Year Return
-41.44 %
5 Year Return
+ 92.02 %

Biocryst Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Biocryst Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

0.1657

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-12.23

Industry PE ratio

-3.9415151515151514

P/B Ratio

0

PEG Ratio

-0.28

EBITDA

58.5M

Revenue (TTM)

557.5M

Profit Margin

-6.41%

Return On Equity TTM

0.00%

Biocryst Pharmaceuticals Inc Stock Valuation

Track how Biocryst Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Biocryst Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 18, 2025

Today (-12.23x)

September 18, 2025

Industry (-3.94x)

September 18, 2025

Highest (0.00x)

September 18, 2025

LowHigh

Today’s Price to Earnings Ratio: -12.23x

Biocryst Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biocryst Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.6B92.02%-12.23-6.41%
BUY$18.3BNA15.7540.36%
BUY$42.0BNA20.8913.81%
BUY$14.2B40.41%42.2313.88%
BUY$65.1B-8.67%25.2927.83%

Stock Returns calculator for Biocryst Pharmaceuticals Inc Stock including INR - Dollar returns

The Biocryst Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biocryst Pharmaceuticals Inc investment value today

Current value as on today

₹1,04,953

Returns

₹4,953

(+4.95%)

Returns from Biocryst Pharmaceuticals Inc Stock

₹0 (0%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Biocryst Pharmaceuticals Inc Stock

Based on 18 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Biocryst Pharmaceuticals Inc. Average target price of $17.2

Biocryst Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Biocryst Pharmaceuticals Inc.

What analysts predicted

53.72%UPSIDE

Target Price

$17.2

Current Price

$7.96

Analyzed by

18 Analysts

Target

$17.20

Biocryst Pharmaceuticals Inc target price $17.2, a slight upside of 53.72% compared to current price of $7.96. According to 18 analysts rating.

Biocryst Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Biocryst Pharmaceuticals Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Biocryst Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
68
82
86
93
92
109
117
131
145
163
Gross Profit
67
81
85
91
91
107
113
125
140
160
Operating Income
-28
-20
-11
-42
-14
8
7
-4
21
29
EBITDA
-24
-45
-8
-38
-10
8
11
-1
24
28
Interest Expense
27
28
27
24
24
24
24
24
23
21
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-74
-35
-63
-35
-12
-13
-25
0
6
Income Tax Expense
0
0
0
-1
0
0
0
0
0
1
Net Income
-53
-75
-36
-61
-35
-12
-14
-26
0
5
Net Profit Margin
-77.54%
-91.31%
-41.67%
-66.09%
-38.14%
-11.59%
-11.99%
-20.37%
0.02%
3.11%

Biocryst Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
48
26
25
20
48
17
157
270
331
450
Gross Profit
46
23
23
20
44
16
149
262
325
438
Operating Income
-39
-48
-57
-94
-99
-174
-177
-148
-103
-2
EBITDA
-37
-48
-56
-90
-96
-167
-121
-143
-116
12
Interest Expense
5
6
8
9
11
14
59
99
108
98
Depreciation
-
-
0
0
0
0
0
1
1
1
Income Before Tax
-43
-55
-65
-101
-108
-182
-181
-244
-226
-86
Income Tax Expense
5
6
7
2
11
13
2
2
0
1
Net Income
-43
-55
-65
-101
-120
-182
-184
-247
-226
-88
Net Profit Margin
-89.15%
-209.25%
-261.18%
-490.25%
-245.86%
-1026.35%
-117.11%
-91.24%
-68.36%
-19.72%

Biocryst Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-75
-36
-61
-35
-12
-14
-26
0
5
Operating Cash Flow
-18
-19
-8
-53
-1
8
-5
-27
41
Investing Cash Flow
-19
23
-28
28
-2
8
17
27
29
Financing Cash Flow
29
1
-3
-1
-1
1
-4
0
-73
Change in Cash
-8
4
-40
-26
-5
18
7
0
-16

Biocryst Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-55
-65
-101
-108
-182
-184
-247
-226
-88
Operating Cash Flow
-53
-41
-92
-89
-135
-142
-161
-95
-52
Investing Cash Flow
23
-66
4
77
-6
15
-128
-131
52
Financing Cash Flow
23
135
62
99
300
359
88
32
-5
Change in Cash
-6
28
-25
87
158
233
-201
-193
-6

Global Institutional Holdings in Biocryst Pharmaceuticals Inc

Funds
Holdings
BlackRock Inc
10.85%
Vanguard Group Inc
10.32%
Kynam Capital Management, LP
4.25%
venBio Select Advisor LLC
4.14%
State Street Corp
3.72%

Insights on Biocryst Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 92.76M → 163.35M (in $), with an average increase of 10.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -26.79M → 5.08M (in $), with an average increase of 41966.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Neurocrine Biosciences Inc. has given 18.5% return, outperforming this stock by 24.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 32.4% return, outperforming this stock by 75.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BCRX stock has moved down by -22.7%

About Biocryst Pharmaceuticals Inc

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.
OrganisationBiocryst Pharmaceuticals Inc
Headquarters4505 Emperor Boulevard, Durham, NC, United States, 27703
IndustryHealth Technology
CEOMr. Jon P. Stonehouse
E-voting on sharesClick here to vote

Key Management of Biocryst Pharmaceuticals Inc

Name

Title

Dr. Yarlagadda S. Babu Ph.D.

Chief Discovery Officer

Mr. Clayton Fletcher

Chief Business Development Officer

Ms. Stephanie Angelini

Chief People Officer & Chief Communications Officer

Dr. William P. Sheridan MBBS

Chief Development Officer

Ms. Alane P. Barnes

Senior VP, Chief Legal Officer & Corporate Secretary

Mr. Babar Ghias

CFO & Head of Corporate Development

Ms. Jinky Ang Rosselli

Chief Data & Insights Officer

Mr. Philip George

Chief Strategy Officer

Mr. Jon P. Stonehouse

CEO & Executive Director

Mr. Charles K. Gayer

President

FAQs

What is Biocryst Pharmaceuticals Inc share price today?

Biocryst Pharmaceuticals Inc share price today is $7.96 as on at the close of the market. Biocryst Pharmaceuticals Inc share today touched a day high of $7.96 and a low of $7.77.

What is the 52 week high and 52 week low for Biocryst Pharmaceuticals Inc share?

Biocryst Pharmaceuticals Inc share touched a 52 week high of $11.31 on and a 52 week low of $6.02 on . Biocryst Pharmaceuticals Inc stock price today i.e. is closed at $7.96,which is 29.62% down from its 52 week high and 32.34% up from its 52 week low.

What is Biocryst Pharmaceuticals Inc's market capitalisation today?

Biocryst Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Biocryst Pharmaceuticals Inc Stock (BCRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biocryst Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biocryst Pharmaceuticals Inc Shares that will get you 0.1884 shares as per Biocryst Pharmaceuticals Inc share price of $7.96 per share as on September 19, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biocryst Pharmaceuticals Inc Stock (BCRX) from India?

Indian investors can start investing in Biocryst Pharmaceuticals Inc (BCRX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Biocryst Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Biocryst Pharmaceuticals Inc share’s latest price of $7.96 as on September 19, 2025 at 1:29 am IST, you will get 1.2563 shares of Biocryst Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Biocryst Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Biocryst Pharmaceuticals Inc stock has given 92.02% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?